ERBB2 and neoplasm: Increased macrophage M2 predicts the tumor's ability to progress through angiogenesis, tissue remodeling, and adaptive immunosuppression25; T-cell CD8 acts as an effector cell against tumor cells, whereas NK cell expression is closely associated with pathological complete response of HER2+ BC26,27.